FOXD2 and colorectal carcinoma: In the current study, our result demonstrated that exosomal FOXD2-AS1, NRIR, and XLOC_009459 were significantly upregulated in CRC and early CRC, thus revealing their potential as diagnostic biomarkers for CRC.